New study aims to make sedation safer for obese joint surgery patients
NCT ID NCT05760534
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 110 obese patients (BMI over 25) having knee or hip replacement surgery under spinal anesthesia. Researchers compared two ways to calculate the dose of the sedative remimazolam: using ideal body weight versus total body weight. The goal was to find which dose reduces breathing problems during surgery while still keeping patients comfortable.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS (KNEE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jin-Tae Kim
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Knee X-Ray study pulled before starting
- Can a pharmacist help patients cut opioids before joint surgery?
- Knee surgery pain relief: could a simple injection replace opioids?
- Weight-Loss surgery before knee replacement: does it help or hurt?
- New knee implant under review: will it hold up?
- Knee cement checked: simplex HV holds up over two years